Last update:
Oncology news
The 'zombie cell' effect: New study explains chemotherapy resistance in lung and ovarian cancers
Researchers have identified a biological mechanism that helps explain why some lung and ovarian cancers become resistant to chemotherapy, offering insight into why cancers recur. The study, published in Nature Aging this ...
9 hours ago
0
29
How pancreatic cancer prepares the tumor environment: A possible biomarker for the earliest stage of development
Even before a tumor in the pancreas becomes discernible, an activated cancer gene actively remodels its future environment and creates an inflammatory and immune-defensive microenvironment in which the carcinoma can grow. ...
12 hours ago
0
0
Study identifies a new class of drug targets for aggressive leukemia
Hyperactive signaling pathways of some aggressive blood cancer cells can be tamped down by a previously unrecognized protein complex, ensuring the cancer's survival. If one component of the complex is deleted or removed, ...
11 hours ago
0
1
Combating leukemia by stopping stem cells from turning cancerous
Acute myeloid leukemia (AML) is an aggressive form of blood cancer. It affects people of all ages but is most common in those over 65. Around 150 people are diagnosed with the disease each year in Norway. Men are affected ...
12 hours ago
0
1
What telehealth changes for adult survivors of childhood cancers: More genetic testing, earlier screening options
Adult survivors of childhood cancers are at higher risk for another cancer—such as breast, colorectal, sarcomas and thyroid cancer—that is not a relapse of their original illness. Previous cancer therapies are largely ...
7 hours ago
0
0
Colorectal cancer is increasing among young people, James Van Der Beek's death reminds
An increasing number of people are dying of colorectal cancer at a young age, including those as young as 20. Actor James Van Der Beek, who was diagnosed with colorectal cancer in 2023, died at age 48 on Feb. 11, 2026, bringing ...
19 hours ago
0
0
Lung cancer drug offers a surprising new treatment against ovarian cancer
A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor treatment, and blocking this early response may make this class of drugs work better. ...
Feb 12, 2026
0
0
Cancer cell study sheds light on cachexia's origins
New research from the University of Oklahoma, published today in Cancer Cell, describes for the first time a "triangle regulation theory" of cancer-induced cachexia and anorexia. Cachexia is a muscle-wasting and fat-loss ...
Feb 12, 2026
0
0
Unraveling the mystery of why some cancer treatments stop working
Cancer researchers working on immunotherapies have made a big discovery: SLAMF6, a molecule on the surface of immune cells that prevents T cells from effectively attacking tumors—and, in mice, they've found a way to neutralize ...
Feb 12, 2026
0
0
Light-based sensor detects early molecular signs of cancer in the blood
Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer biomarkers in the blood. The new technology could one day make it possible to spot early signs of cancer ...
Feb 12, 2026
0
1
New characteristics of aggressive prostate cancer identified
For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can probably be detected through ...
Feb 12, 2026
0
0
Best diagnostic test for ovarian cancer in premenopausal women identified
Premenopausal women would benefit from a significantly more accurate diagnostic pathway for ovarian cancer, as a new study finds that an advanced ultrasound test, IOTA ADNEX, identified 9 out of 10 cancers in women who took ...
Feb 12, 2026
0
0
Genetic risk may rival obesity as a key driver of endometrial cancer
A major new study has found genetics play a powerful and independent role in endometrial cancer risk—challenging the long-held belief that obesity is the primary driver. The findings could lead to better screening of the ...
Feb 12, 2026
0
0
Antibody-drug conjugate achieves high response rates as frontline treatment in aggressive, rare blood cancer
Seventy-five percent of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) who were treated with the antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) had a complete response, according to new data from ...
Feb 12, 2026
0
0
Rallying more T-cells to immunotherapy's fight against cancer
Immune Checkpoint Blockade (ICB) has revolutionized the treatment of cancers like melanoma, but up to 60% of patients don't respond to this immunotherapy for reasons not yet fully understood. Australian scientists have found ...
Feb 12, 2026
0
0
Colorectal cancer is rising in younger adults. Here's who is most at risk and symptoms to watch for
Colorectal cancer is a threat not just to older adults but increasingly to young men and women, too. It's now the top cancer killer of Americans younger than 50.
Feb 12, 2026
0
1
Researchers develop metastasis prevention therapy based on glycan targeting
A research team led by Prof. Kenward Vong, Assistant Professor from the Department of Chemistry at The Hong Kong University of Science and Technology (HKUST) has recently achieved a significant breakthrough by bioengineering ...
Feb 12, 2026
0
0
Study strengthens evidence supporting lung-sparing surgery, offering hope for mesothelioma patients
A new study from the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center finds that pleurectomy/decortication, a lung-sparing surgery, can be performed safely with low mortality in carefully selected ...
Feb 12, 2026
0
0
New research results in changes to NHS guidelines
Hundreds of people with advanced bladder cancer across the UK can now receive three rather than six chemotherapy cycles following research by Queen Mary University of London which has led to a change to NHS treatment guidelines. ...
Feb 12, 2026
0
0
Pancreatic cancer: Warning signs to heed
Your pancreas has important jobs to do. A large gland behind the lower part of the stomach, it produces hormones that regulate blood sugar and enzymes that help digest food. What if it develops cancer?
Feb 12, 2026
0
0
A single oncolytic virus injection may help T cells infiltrate glioblastoma
A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute has shown that a single injection of an oncolytic virus—a genetically modified virus that selectively infects and destroys cancer cells—can ...
Feb 11, 2026
0
80
New AI tool helps scientists see how cells work together inside diseased tissue
Doctors and scientists have long relied on microscopes to study human tissue and diagnose disease. But today's medical research produces far more information than the human eye alone can handle, including detailed maps of ...
Feb 11, 2026
0
0
HPV cancer vaccine slows tumor growth and extends survival in preclinical model
Throughout the past decade, Northwestern University scientists have uncovered a striking principle of vaccine design: Performance depends not only on vaccine components but also on vaccine structure. After proving this concept ...
Feb 11, 2026
0
13
Doctors discover a simple method to predict the risk of brain tumor recurrence
Meningioma is the most common type of brain tumor. It does not develop in the brain tissue itself, but on the inside of the meninges, the membranes that surround the brain. In most cases, a meningioma is benign. However, ...
Feb 11, 2026
0
0
Aggressive brain tumors build protective 'sugar shield' to survive extreme stress
For the first time, researchers have identified a previously unrecognized metabolic defense mechanism in aggressive brain tumors: a sugar-rich shield that surrounds tumor cells and protects them against a particularly destructive ...
Feb 11, 2026
0
0
